Intensive glucose control offers no benefit after kidney transplant

11/5/2012 | Modern Medicine

Researchers found statistically similar rates of delayed graft function following kidney transplant in diabetes patients receiving intensive glucose control and a control group. The study in the Journal of Clinical Endocrinology & Metabolism also found an blood glucose target of less than 180 mg/dL was associated with a lower risk of organ rejection than targets of 70-110 mg/dL, suggesting tight glycemic control may offer no help immediately after the procedure.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA